Robert Hast

<i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Martin Jädersten, Leonie Saft, Alexander Smith et al. · Journal of Clinical Oncology · 2011 · 460 citations · Full text

Medicine, Hematology, Oncology +17

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission

Ramin Tehranchi, Petter Woll, Kristina Anderson et al. · New England Journal of Medicine · 2010 · 250 citations · Full text

Medicine, Hematology, Oncology +17

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

Lars Nilsson, Ingbritt Åstrand‐Grundström, Ingrid Arvidsson et al. · Blood · 2000 · 239 citations

Life Sciences, Genetics, Hematology +16

Involvement and functional impairment of the CD34+CD38−Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8

Lars Nilsson, Ingbritt Åstrand‐Grundström, Kristina Anderson et al. · Blood · 2002 · 162 citations · Full text

Life Sciences, Genetics, Hematology +12

The molecular signature of MDS stem cells supports a stem-cell origin of 5q− myelodysplastic syndromes

Lars Nilsson, Patrik Edén, Eleonor Olsson et al. · Blood · 2007 · 111 citations

Life Sciences, Cell Biology, Molecular Biology +9